Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Prif Awduron: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2009
|
Eitemau Tebyg
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
gan: Rolinski, M, et al.
Cyhoeddwyd: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
gan: Ballard, C, et al.
Cyhoeddwyd: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
gan: Chalmers, K, et al.
Cyhoeddwyd: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
gan: McShane, R, et al.
Cyhoeddwyd: (2001) -
Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
gan: Pai-Yi Chiu, et al.
Cyhoeddwyd: (2017-01-01)